AU7930987A – Human macrophage migration inhibition factor related peptide
– Google Patents
AU7930987A – Human macrophage migration inhibition factor related peptide
– Google Patents
Human macrophage migration inhibition factor related peptide
Info
Publication number
AU7930987A
AU7930987A
AU79309/87A
AU7930987A
AU7930987A
AU 7930987 A
AU7930987 A
AU 7930987A
AU 79309/87 A
AU79309/87 A
AU 79309/87A
AU 7930987 A
AU7930987 A
AU 7930987A
AU 7930987 A
AU7930987 A
AU 7930987A
Authority
AU
Australia
Prior art keywords
related peptide
factor related
macrophage migration
human macrophage
inhibition factor
Prior art date
1986-10-03
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU79309/87A
Inventor
Josef Bruggen
Nico Cerletti
Roger Clerc
Karel Gerrit Odink
Clemens Sorg
Lajos Tarcsay
Walter Wiesendanger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1986-10-03
Filing date
1987-10-02
Publication date
1988-05-19
1986-10-03
Priority claimed from GB868623850A
external-priority
patent/GB8623850D0/en
1986-11-27
Priority claimed from GB868628358A
external-priority
patent/GB8628358D0/en
1987-10-02
Application filed by Ciba Geigy AG
filed
Critical
Ciba Geigy AG
1988-05-19
Publication of AU7930987A
publication
Critical
patent/AU7930987A/en
Status
Abandoned
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
102000009073
Macrophage Migration-Inhibitory Factors
Human genes
0.000
title
1
108010048043
Macrophage Migration-Inhibitory Factors
Proteins
0.000
title
1
108090000765
processed proteins & peptides
Proteins
0.000
title
1
Classifications
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07K—PEPTIDES
C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07K—PEPTIDES
C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
C07K14/52—Cytokines; Lymphokines; Interferons
C—CHEMISTRY; METALLURGY
C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
C12N15/09—Recombinant DNA-technology
C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K38/00—Medicinal preparations containing peptides
C—CHEMISTRY; METALLURGY
C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
C12N2830/00—Vector systems having a special element relevant for transcription
C—CHEMISTRY; METALLURGY
C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
C12N2830/00—Vector systems having a special element relevant for transcription
C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
C—CHEMISTRY; METALLURGY
C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
C12N2830/00—Vector systems having a special element relevant for transcription
C12N2830/55—Vector systems having a special element relevant for transcription from bacteria
C—CHEMISTRY; METALLURGY
C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
C12N2830/00—Vector systems having a special element relevant for transcription
C12N2830/70—Vector systems having a special element relevant for transcription from fungi
C12N2830/702—Vector systems having a special element relevant for transcription from fungi yeast
AU79309/87A
1986-10-03
1987-10-02
Human macrophage migration inhibition factor related peptide
Abandoned
AU7930987A
(en)
Applications Claiming Priority (4)
Application Number
Priority Date
Filing Date
Title
GB868623850A
GB8623850D0
(en)
1986-10-03
1986-10-03
Lymphokine related peptide
GB8628358
1986-11-27
GB8623850
1986-11-27
GB868628358A
GB8628358D0
(en)
1986-11-27
1986-11-27
Lymphokine related peptides
Publications (1)
Publication Number
Publication Date
AU7930987A
true
AU7930987A
(en)
1988-05-19
Family
ID=26291377
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU79309/87A
Abandoned
AU7930987A
(en)
1986-10-03
1987-10-02
Human macrophage migration inhibition factor related peptide
Country Status (11)
Country
Link
US
(2)
US5350687A
(en)
EP
(1)
EP0263072B1
(en)
JP
(1)
JPH09188698A
(en)
AU
(1)
AU7930987A
(en)
DE
(1)
DE3789413T2
(en)
DK
(1)
DK517787A
(en)
ES
(1)
ES2052602T3
(en)
FI
(1)
FI874287A
(en)
IE
(1)
IE61773B1
(en)
NO
(1)
NO874159L
(en)
PT
(1)
PT85849B
(en)
Cited By (1)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
AU649226B2
(en)
*
1989-07-05
1994-05-19
Novartis Ag
Novel cytokines
Families Citing this family (29)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
FR2750604B1
(en)
*
1996-07-02
2002-09-20
Oreal
HETEROMER BINDING ARACHIDONIC ACID AND ITS USE IN COSMETICS OR PHARMACY
CA2050332A1
(en)
*
1989-03-17
1990-09-18
Steven C. Clark
Human macrophage migration inhibitory factor
JP2747839B2
(en)
*
1989-08-14
1998-05-06
花王株式会社
Monoclonal antibody
US5149544A
(en)
*
1989-11-13
1992-09-22
Research Corporation Technologies, Inc.
Method of inhibiting progenitor cell proliferation
DE69133159D1
(en)
*
1990-09-05
2003-01-02
Heart Res Inst Ltd
CHEMOTACTIC FACTORS
CH685959A5
(en)
*
1992-08-24
1995-11-15
Biomedicals Ag
Diagnostic test kit for the determination of proteins.
US6030615A
(en)
*
1993-05-17
2000-02-29
The Picower Institute For Medical Research
Combination method for treating diseases caused by cytokine-mediated toxicity
US5776348A
(en)
*
1995-02-07
1998-07-07
Massachusetts Institute Of Technology
Mineral precipitation system and method for inhibiting mineral precipitate formation
CA2278248A1
(en)
1997-01-21
1998-07-23
Human Genome Sciences, Inc.
Human proteins
EP1118681A1
(en)
1998-09-29
2001-07-25
Asahi Kasei Kabushiki Kaisha
Method for controlling the release of granules
AU773265B2
(en)
*
1998-11-05
2004-05-20
Regents Of The University Of Michigan, The
S100 proteins and autoantibodies as serum markers for cancer
MY140679A
(en)
2001-05-24
2010-01-15
Avanir Pharmaceuticals
Inhibitors of macrohage migration inhibitory factor and methods for identifying the same
AU2003212246A1
(en)
*
2002-02-15
2003-09-04
Johannes Roth
Method for diagnosis of inflammatory diseases using mrp8/mrp14
EP1519749B1
(en)
2002-07-05
2009-04-08
Universite Laval
Chemotactic factor inhibitor for inhibiting inflammatory reactions
TW200418829A
(en)
2003-02-14
2004-10-01
Avanir Pharmaceutics
Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
US7361474B2
(en)
*
2003-02-24
2008-04-22
United States Of America As Represented By The Department Of Veterans Affairs
Serum macrophage migration inhibitory factor (MIF) as marker for prostate cancer
EP1608397B1
(en)
2003-03-28
2008-10-15
Universite Laval
S100 protein as neutrophil activator for alleviating neutropenia in cancer treatment
EP1656376A1
(en)
*
2003-08-22
2006-05-17
Avanir Pharmaceuticals
Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases
US20050196795A1
(en)
*
2004-02-25
2005-09-08
Siegler Katherine M.
Methods for diagnosing and treating bladder cancer
SE0400886D0
(en)
*
2004-04-02
2004-04-02
Amersham Biosciences Ab
Process of purification
WO2006005186A1
(en)
*
2004-07-13
2006-01-19
UNIVERSITé LAVAL
S100 protein inhibitors for treating leukemia
US7659087B2
(en)
2004-07-23
2010-02-09
Aspenbio Pharma, Inc.
Methods and devices for diagnosis of appendicitis
NZ580805A
(en)
2004-07-23
2011-02-25
Aspenbio Pharma Inc
Methods and devices for diagnosis of appendicitis
WO2006102191A1
(en)
2005-03-24
2006-09-28
Avanir Pharmaceuticals
Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors
GB0605689D0
(en)
*
2006-03-21
2006-05-03
Novartis Ag
Organic compounds
EP3075867B1
(en)
*
2008-09-03
2019-03-13
Quantumdx Group Limited
Sensing strategies and methods for nucleic acid detection using biosensors
EP2711682B1
(en)
2011-05-20
2019-07-10
Riken
Clarifying reagent for biological materials and use thereof
EP2748613B1
(en)
2011-10-07
2021-05-05
Baxalta GmbH
Oxmif as a diagnostic marker
EP3183581A1
(en)
*
2014-08-22
2017-06-28
Baxalta GmbH
Detection of cho-mif contaminations
Family Cites Families (9)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
DE230876C
(en)
*
US4322274A
(en)
*
1980-08-28
1982-03-30
Wilson Gregory B
Method of diagnosing cystic fibrosis patients and asymptomatic carrier of the cystic fibrosis gene
GB2125047B
(en)
1982-08-09
1986-02-19
Ciba Geigy Ag
Yeast hybrid vectors and their use for the production of polypeptides
GB8318754D0
(en)
*
1983-07-11
1983-08-10
Fagerhol M K F
Human proteins anti-sera test kits
JPS6041697A
(en)
*
1983-08-15
1985-03-05
Asahi Chem Ind Co Ltd
Novel synthesis of active protein derivative
FI86746C
(en)
1983-11-21
1992-10-12
Ciba Geigy Ag
FOERFARANDE FOERFARANDE AV MAENSKLIG VAEVNADS PLASMINOGENAKTIVATOR (TPA) MED HJAELP AV SACCHAROMYCES CEREVISIAE -JEST OCH I FOERFARANDET ANVAENDA HYBRIDVEKTORER
PT79519B
(en)
1983-11-21
1986-12-11
Ciba Geigy Ag
Process for preparing protease inhibitors based on egline compounds
JPH0672158B2
(en)
*
1984-05-24
1994-09-14
チバ−ガイギ− アクチエンゲゼルシヤフト
Purified human macrophage migration inhibitory factor
GB8915414D0
(en)
*
1989-07-05
1989-08-23
Ciba Geigy
Novel cytokines
1987
1987-09-28
DE
DE3789413T
patent/DE3789413T2/en
not_active
Expired – Fee Related
1987-09-28
ES
ES87810561T
patent/ES2052602T3/en
not_active
Expired – Lifetime
1987-09-28
EP
EP87810561A
patent/EP0263072B1/en
not_active
Expired – Lifetime
1987-09-30
FI
FI874287A
patent/FI874287A/en
not_active
IP Right Cessation
1987-10-01
PT
PT85849A
patent/PT85849B/en
not_active
IP Right Cessation
1987-10-02
AU
AU79309/87A
patent/AU7930987A/en
not_active
Abandoned
1987-10-02
IE
IE264587A
patent/IE61773B1/en
not_active
IP Right Cessation
1987-10-02
NO
NO874159A
patent/NO874159L/en
unknown
1987-10-02
DK
DK517787A
patent/DK517787A/en
not_active
Application Discontinuation
1990
1990-11-21
US
US07/617,485
patent/US5350687A/en
not_active
Expired – Fee Related
1995
1995-07-27
US
US08/508,142
patent/US5702920A/en
not_active
Expired – Fee Related
1996
1996-12-18
JP
JP8338746A
patent/JPH09188698A/en
active
Pending
Cited By (1)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
AU649226B2
(en)
*
1989-07-05
1994-05-19
Novartis Ag
Novel cytokines
Also Published As
Publication number
Publication date
FI874287A0
(en)
1987-09-30
IE872645L
(en)
1988-04-03
EP0263072B1
(en)
1994-03-23
DE3789413D1
(en)
1994-04-28
US5350687A
(en)
1994-09-27
DK517787D0
(en)
1987-10-02
EP0263072A2
(en)
1988-04-06
IE61773B1
(en)
1994-11-30
US5702920A
(en)
1997-12-30
DK517787A
(en)
1988-04-04
PT85849B
(en)
1990-07-31
EP0263072A3
(en)
1990-01-10
PT85849A
(en)
1987-11-01
JPH09188698A
(en)
1997-07-22
NO874159L
(en)
1988-04-05
NO874159D0
(en)
1987-10-02
DE3789413T2
(en)
1994-07-28
FI874287A
(en)
1988-04-04
ES2052602T3
(en)
1994-07-16
Similar Documents
Publication
Publication Date
Title
AU7930987A
(en)
1988-05-19
Human macrophage migration inhibition factor related peptide
GB2199831B
(en)
1991-04-17
Peptide derivatives
AU581367B2
(en)
1989-02-16
Chair
AU584297B2
(en)
1989-05-18
Chair
PT81887A
(en)
1986-02-01
Peptide derivatives
AU7336587A
(en)
1987-12-03
Coated dosage forms
AU579089B2
(en)
1988-11-17
Human interleukin-2-like polypeptides
AU574316B2
(en)
1988-06-30
Chair
IL81175A0
(en)
1987-08-31
Human preproinsulin-like factor i
AU590016B2
(en)
1989-10-26
Peptides
AU580748B2
(en)
1989-02-02
Novel human interferon-« polypeptide derivative
AU578005B2
(en)
1988-10-06
Easy chair
AU5831286A
(en)
1986-12-11
Human laminin
AU7831487A
(en)
1988-03-17
Human prorelaxin
AU3446589A
(en)
1989-11-03
Tomography
AU6182886A
(en)
1987-03-05
Furniture covering
AU583668B2
(en)
1989-05-04
Chair
GB9011637D0
(en)
1990-07-11
Peptide derivatives
GB8826452D0
(en)
1988-12-14
Peptide derivatives
ZA877688B
(en)
1989-06-28
Peptide derivatives
IE860363L
(en)
1986-08-12
Peptide derivatives
AU95467S
(en)
1987-03-12
Lounging chair
MW486A1
(en)
1987-09-09
Peptide derivatives
AU5891286A
(en)
1987-02-12
Covering
GB8803479D0
(en)
1988-03-16
Polypeptide derivatives
None